Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Determine the Effect of Ferric Citrate on Time to a Composite Endpoint of Initiation of Maintenance Dialysis or All-cause Mortality vs Placebo in Adults With Advanced CKD

NCT05085275 is registered in ClinicalTrials.gov with USRC Kidney Research as lead sponsor.

NCT NCT05085275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05085275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Determine the Effect of Ferric Citrate on Time to a Composite Endpoint of Initiation of Maintenance Dialysis or All-cause Mortality vs Placebo in Adults With Advanced CKD
Lead sponsor
USRC Kidney Research
Phase
Phase 3
Overall status
Completed
Start date
March 30, 2022
Completion date
January 24, 2024
Enrollment
289 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, iron deficiency, cardiovascular, disease progression, hyperphosphatemia, iron, renal anemia, renal insufficiency, chronic